Management Team

AMAL Therapeutics is led by a dedicated team with a strong background in molecular and cellular biotechnology R&D gained from working within start-ups, at renowned Academic Institutes, as well as large pharma companies.

 

Dr Madiha Derouazi
Founder and CEO
Dr Laetitia Devy-Dimanche
Chief Operating Officer
Dr Thomas Bogenrieder
Chief Clinical Officer
Dr Keith Wilson
VP CMC & Manufacturing
Dr Elodie Belnoue
Senior Director - Translational Research
Dr Marie-Laure Santiago-Raber
Senior Director - Non-Clinical Development
Dr Matteo Rossi
Head of in vivo Research